Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Randomized, Cross-over, Active-controlled Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients

NCT01095016 is registered in ClinicalTrials.gov with Taiwan Otsuka Pharm. Co., Ltd as lead sponsor.

NCT NCT01095016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01095016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Randomized, Cross-over, Active-controlled Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients
Lead sponsor
Taiwan Otsuka Pharm. Co., Ltd
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2010
Completion date
October 31, 2012
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma